If you are prone to depression, a new study suggests you should avoid indulging on dietary sugars. Added sugars have a pro-inflammatory effect on depressive disorders. Read More
A new study reveals neuroimaging may prove useful in revealing patients with depression who may respond well to psychotherapy. Read More
Antidepressants for major depressive disorder reduce the aversive response triggered by exposure to the suffering of others. Findings suggest antidepressants may lead to impaired empathy of pain perception. Read More
A new mouse study discovers different networks of brain activity in animals more susceptible to developing depression following a stressful event. Read More
Examining the impact of eight types of early life stress on the onset of youth-onset depression, researchers found some had little impact on the development of the psychological disorder. Emotional abuse was more strongly associated with the development of major depressive disorder than other early stressors, such as poverty. Read More
Transcranial alternating current brain stimulation (tACS) significantly reduced symptoms in people diagnosed with major depressive disorder in a pilot clinical trial. Read More
Researchers report 1 in 5 people are at risk of experiencing mental health conditions, such as PTSD or major depressive disorder, within 6 months of suffering mTBI. Read More
A new study reports aerobic exercise can have antidepressant effects for patients with major depressive disorder. Read More
Researchers report pupil dilation in reaction to negative facial expressions could predict a risk for relapse in those with depression. Read More
A new study reports those who suffer from persistent depression lasting more than ten years have higher levels of neuroinflammation. Read More
The side effects of administering ketamine to treat major depressive disorder are mild and persist for no longer than four hours, researchers report. Most of the side effects peaked within an hour of treatment, and many patients reported the effects as being significantly reduced two hours post ketamine administration. Read More
Ezogabine, an FDA approved anti-convulsant, appears to significantly reduce symptoms in those with major depressive disorder. Read More
